Drug Approval | April 18, 2024
Jubilant Pharmova’s Roorkee unit gets VAI status
FDA has concluded that this inspection is 'closed'
FDA has concluded that this inspection is 'closed'
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Cipla completes transfer of Generics Business Undertaking
BHL will undertake the development and supply of these molecules
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
The product has been in-licensed from Strides and will be commercialized by Amneal
This approval showcases Teva’s proven strengths in complex generic formulations development and device engineering
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Subscribe To Our Newsletter & Stay Updated
